Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by gojotv!on Mar 07, 2022 9:34am
187 Views
Post# 34489813

Real investors aren't looking for an early buyout

Real investors aren't looking for an early buyoutWhen I see the effort being made to seed the idea in our heads that we'd be better off selling our shares for a tiny fraction of their fair value... I have to laugh.
Truth is, investors would be MUCH better off waiting for developments in new cancer indications, such as; glioblastoma, lung, prostate, etc...
Their posts go against the wishes of the majority of large investors, who want to see Canada develop an international Pharma-Tech corporation to secure the nation's healthcare while keeping high-tech jobs here.
Theralase could be the Oncology-Virology-Laser Pharma giant that cures the greatest threats to world health today.
You don't just sell that for pennies.
GLTA!


<< Previous
Bullboard Posts
Next >>